Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Common Equity (2020 - 2025)

Historic Common Equity for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to $292.3 million.

  • GeneDx Holdings' Common Equity rose 4291.27% to $292.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $292.3 million, marking a year-over-year increase of 4291.27%. This contributed to the annual value of $245.2 million for FY2024, which is 755.65% up from last year.
  • Per GeneDx Holdings' latest filing, its Common Equity stood at $292.3 million for Q3 2025, which was up 4291.27% from $277.1 million recorded in Q2 2025.
  • GeneDx Holdings' Common Equity's 5-year high stood at $637.3 million during Q2 2022, with a 5-year trough of -$566.5 million in Q2 2021.
  • Over the past 5 years, GeneDx Holdings' median Common Equity value was $257.4 million (recorded in 2025), while the average stood at $224.1 million.
  • Per our database at Business Quant, GeneDx Holdings' Common Equity surged by 772041.37% in 2021 and then tumbled by 5470.15% in 2023.
  • Over the past 5 years, GeneDx Holdings' Common Equity (Quarter) stood at $388.1 million in 2021, then tumbled by 34.63% to $253.7 million in 2022, then decreased by 10.13% to $228.0 million in 2023, then grew by 7.56% to $245.2 million in 2024, then increased by 19.17% to $292.3 million in 2025.
  • Its Common Equity stands at $292.3 million for Q3 2025, versus $277.1 million for Q2 2025 and $257.4 million for Q1 2025.